Junsheng

Junsheng Ma is a seasoned biostatistician with extensive experience in the field, including a significant tenure at The University of Texas Health Science Center at Houston from January 2010 to December 2013 as a PhD student and research assistant, focusing on Bayesian approaches in clinical trial analysis for Alzheimer's and Parkinson's diseases. Following this, Junsheng Ma served as a postdoctoral fellow and senior biostatistician at MD Anderson Cancer Center from July 2016 to November 2021, where expertise was developed in statistical methods for personalized treatment rules using high-dimensional data. In subsequent roles at Eli Lilly and Company as senior director of biostatistics and prior positions at POINT Biopharma and Sumitomo Pharma Oncology, Junsheng Ma continued to build a robust career in biostatistics, complemented by a Master’s Degree from The University of Texas at Austin and a Doctor of Philosophy from The University of Texas Health Science Center School of Public Health.